It prevents an overstimulation of the inflammatory response through its recognised target genes, IRAK-1 and TRAF-6 [16, 18], and its dysregulation is associated with many inflammatory diseases including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) [15]. Here, TRAF6 is linked to rheumatoid arthritis.